Astellas Pharma Inc., Daiichi Sankyo Company, Limited, and Takeda Pharmaceutical Company Limited announced that they have entered into a joint research agreement. It is...
Engitix Ltd., a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, April...
The Takeda Pharmaceutical Co-led group that is developing a blood plasma treatment for COVID-19 has started manufacturing while the late-stage trial to determine whether...